Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancerKrishan R. Jethwa, Christopher L. Hallemeier, Michael G. Haddock et al.|Radiotherapy and Oncology|2020Cited by 37
Initial experience with intensity modulated proton therapy for intact, clinically localized pancreas cancer: Clinical implementation, dosimetric analysis, acute treatment-related adverse events, and patient-reported outcomesKrishan R. Jethwa, Christopher L. Hallemeier, E. Tryggestad et al.|Advances in Radiation Oncology|2018Cited by 29
A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal CancerAurélie Garant, Christopher L. Hallemeier, Thomas J. Whitaker et al.|Practical Radiation Oncology|2019Cited by 25
A Multi-Institutional Analysis of Radiation Dosimetric Predictors of Toxicity After Trimodality Therapy for Esophageal CancerAurélie Garant, Kenneth W. Merrell, Grant M. Spears et al.|Practical Radiation Oncology|2021Cited by 18
Predictors of lymphopenia in esophageal cancer patients receiving photon or proton radiation therapy: A dosimetric analysis.David M. Routman, Kenneth W. Merrell, Thomas J. Whitaker et al.|Journal of Clinical Oncology|2019Cited by 2